Related Experiment Video

Updated: Jun 25, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

Marc C Chamberlain

    Neurology
    |February 25, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations04:46

    Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

    Published on: February 24, 2023

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

    Published on: April 16, 2019

    Related Concept Videos

    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...